Source - LSE Regulatory
RNS Number : 2522H
Oxford Nanopore Technologies plc
07 October 2024
BLOCK LISTING SIX MONTHLY RETURN
Date: 07 October 2024
| Name of applicant: | Oxford Nanopore Technologies plc | |||
| Name of scheme: | Oxford Nanopore Technologies plc Share Option Schemes | |||
| Period of return: | From: | 06-Apr-2024 | To: | 05-Oct-2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 22,324,455 ordinary shares of £0.0001 each | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 3,755,229 | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 18,569,226 | |||
| Name of contact: | Jordan Herman, General Counsel |
| Telephone number of contact: | 07917 931457 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
